Cap-dependent endonuclease-IN-3

Cap-dependent endonuclease-IN-3 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent endonuclease-IN-3 inhibit influenza virus well, but also has lower cytotoxicity, better in vivo agent kinetic properties and in vivo pharmacodynamic properties. Cap-dependent endonuclease-IN-3 has the potential for the research of influenza A and influenza B infection (extracted from patent WO2019141179A1, compound VI-1)[1].

Signaling Pathways >> Anti-infection >> Influenza Virus

Research Areas >> Infection

[1]. Li Chen, et al. Pyridone derivative, its composition and application as anti-influenza virus drug. Patent WO2019141179A1.